无菌保证水平（SAL）

The concept of the Sterility Assurance Level (SAL) is rooted in the understanding that microbial death follows first-order kinetics, meaning it is a probabilistic event. It is impossible to prove that every single microorganism on an object has been killed; one can only calculate the probability of a microbe surviving the process. The SAL is this probability. For instance, an SAL of [latex]10^{-6}[/latex] does not mean one contaminated item exists for every million produced. Instead, it means there is a one-in-a-million chance for any given item to harbor a single viable microorganism after the sterilization process. This statistical approach is fundamental to the validation of sterilization cycles in regulated industries like pharmaceuticals and medical devices. To establish a cycle that achieves a desired SAL, manufacturers perform validation studies. This often involves placing biological indicators (BIs), which are standardized preparations of highly resistant bacterial spores (like Geobacillus stearothermophilus for steam or Bacillus atrophaeus for EtO), in the most challenging locations within a sterilization load. The process parameters (e.g., time, temperature, concentration) are then adjusted and tested until they consistently achieve a complete kill of the BIs. The cycle is then extended for a ‘half-cycle’ or more to provide a safety margin, ensuring the process can deliver the target SAL of [latex]10^{-6}[/latex] or better. The choice of SAL depends on the intended use of the product. Items that will come into contact with compromised tissue, such as surgical implants and injectable drugs, require the most stringent SAL of [latex]10^{-6}[/latex]. For items that contact intact skin, a lower SAL of [latex]10^{-3}[/latex] may be acceptable.

在美国食品药品监督管理局 (FDA) 和国际标准化组织 (ISO) 等机构的推动下，SAL 作为一项监管标准正式确立于 20 世纪下半叶。在此之前，无菌通常被视为一种绝对状态——物品要么无菌，要么非无菌。然而，随着生产规模的扩大以及对污染风险的理解加深，需要一个更严格、更定量的框架。这种从定性到概率的无菌定义转变是一项重大进步。它为工艺验证提供了科学且可靠的基础，使制造商能够向监管机构证明其灭菌方法的有效性和可重复性，并确保患者获得始终如一的安全保障。